Angola vs Gabon: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Angola
3.1%
in 2024
Gabon
3.2%
in 2024
Angola rank
5th
Gabon rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Angola
- Gabon
How they compare
Gabon currently reports 3.2% against 3.1% in Angola, a difference of 0.1%.
Across all 10 years both countries report, Gabon has been ahead every year.
Angola ranks 5th and Gabon ranks 3rd of 215 countries.
Gabon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 2.9% | 0.3% | Gabon |
| 2020s | 3.0% | 3.1% | 0.1% | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Angola or Gabon?
- Gabon, at 3.2% against 3.1% in Angola as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Angola and Gabon?
- 0.1%, with Gabon ahead.
- How many years of comparable data are there for Angola and Gabon?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and Gabon rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Angola ranks 5th and Gabon ranks 3rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.